Common Contracts
8 similar Lock-Up Agreement contracts by 180 Life Sciences Corp., Aclarion, Inc., Alpine 4 Holdings, Inc., others
LOCK-UP AGREEMENTLock-Up Agreement • February 6th, 2024 • Aclarion, Inc. • Services-medical laboratories
Re: Securities Purchase Agreement, dated [***], 2024, by and among Aclarion, Inc. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”).
LOCK-UP AGREEMENTLock-Up Agreement • December 11th, 2023 • Aclarion, Inc. • Services-medical laboratories
Re: Securities Purchase Agreement, dated December [***], 2023, by and among Aclarion, Inc. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”).
LOCK-UP AGREEMENTLock-Up Agreement • November 16th, 2023 • reAlpha Tech Corp. • Real estate
Re: Securities Purchase Agreement, dated as of [___], 2023 (the “Purchase Agreement”), between reAlpha Tech Corp. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”)
LOCK-UP AGREEMENTLock-Up Agreement • September 21st, 2023 • Alpine 4 Holdings, Inc. • Communications equipment, nec
Re: Securities Purchase Agreement, dated as of the date hereof (the “Purchase Agreement”), between Alpine 4 Holdings, Inc. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”)
LOCK-UP AGREEMENTLock-Up Agreement • September 19th, 2022 • Creatd, Inc. • Services-allied to motion picture production • New York
Re: Securities Purchase Agreement, dated as of September 15, 2022 (the “Purchase Agreement”), between Creatd, inc. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”)
LOCK-UP AGREEMENTLock-Up Agreement • August 24th, 2021 • 180 Life Sciences Corp. • Pharmaceutical preparations • New York
LOCK-UP AGREEMENTLock-Up Agreement • August 24th, 2021 • NRX Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
Re: Securities Purchase Agreement, dated as of August 19, 2021 (the “Purchase Agreement”), between NRX Pharmaceuticals, Inc. (the “Company”) and the purchasers signatory thereto (each, a “Purchaser” and, collectively, the “Purchasers”)
LOCK-UP AGREEMENTLock-Up Agreement • February 24th, 2021 • 180 Life Sciences Corp. • Pharmaceutical preparations • New York
